Sharpless featured in IBM podcast series highlighting innovators

August 3, 2015

Each month, the technology company IBM releases a podcast called “Wild Ducks,” focusing on world-changing people and ideas. For the month of July, IBM came to UNC Lineberger Comprehensive Cancer Center to learn about personalized medicine and meet their newest Wild Duck – Ned Sharpless, MD, UNC Lineberger Director and Wellcome Distinguished Professor in Cancer Research at the UNC School of Medicine.

Ewend receives Fuller Award

November 26, 2014

Matthew G. Ewend, MD, FACS, Van L. Weatherspoon, Jr. Eminent Distinguished Professor and Chair, UNC Department of Neurosurgery and UNC Lineberger member, has been awarded this year’s H. Fleming Fuller Award.

UNC Lineberger to offer sequencing expertise to NCI clinical trials networks

May 23, 2014

Personalized medicine holds great promise for delivering targeted treatments to patients based on their unique genetic characteristics. Through a $3.5 million, five-year grant from the National Cancer Institute (NCI), UNC Lineberger Comprehensive Cancer Center will provide high-throughput RNA and DNA sequencing and regulatory assistance to partner institutions in the NCI’s new National Clinical Trials Network (NCTN).